Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2026-03-06 @ 6:14 PM
Study NCT ID:
NCT00691704
Status:
COMPLETED
Last Update Posted:
2014-08-19
First Post:
2008-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Sponsor:
Organization: